Twitter
youtube
Discord
Contact us
Forums
New posts
Trending
Rules
Explore
Bioenergetic Wiki
Bioenergetic Life Search
Bioprovement Peat Search
Ray Peat Interviews by Danny Roddy
Master List: Ray Peat, PhD Interviews & Quotes by FPS
Traveling Resources
Google Flights
Wiki Voyage
DeepL Translator
Niche
Numbeo
Merch
Log in
Register
What's new
Search
Search
Search engine:
Threadloom Search
XenForo Search
Search titles only
By:
New posts
Trending
Menu
Log in
Register
Navigation
Install the app
Install
More options
Light/Dark Mode
Contact us
Close Menu
Information
World News
Pfizer tops Q1 expectations, revises 2022 forecast
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="WPLG" data-source="post: 26199" data-attributes="member: 158"><p>Sales of Pfizer’s COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%.</p><p></p><p>The coronavirus vaccine Comirnaty brought in more than $13 billion in sales, and the treatment Paxlovid added another $1.5 billion as company revenue swelled 77%, the company said Tuesday.</p><p></p><p>Pfizer posted adjusted earnings of $1.62 per share in the first quarter, on $25.66 billion in revenue.</p><p></p><p>Analysts expected per-share earnings of $1.49 on about $24.1 billion in sales, according to FactSet.</p><p></p><p>Pfizer Inc., based in New York, also revised its 2022 earnings forecast to reflect an accounting policy change. It now expects adjusted earnings of $6.25 to $6.45 per share.</p><p></p><p>That's down from its previous forecast for $6.35 to $6.55 per share.</p><p></p><p>Analysts forecast earnings of $7.14 per share.</p><p></p><p>Shares ticked slightly higher before the opening bell Thursday.</p><p></p><p><a href="https://www.local10.com/business/2022/05/03/pfizer-tops-q1-expectations-revises-2022-forecast/" target="_blank">Continue reading...</a></p></blockquote><p></p>
[QUOTE="WPLG, post: 26199, member: 158"] Sales of Pfizer’s COVID-19 vaccine and treatment pushed the drugmaker well past expectations in the first quarter, as profit grew 61%. The coronavirus vaccine Comirnaty brought in more than $13 billion in sales, and the treatment Paxlovid added another $1.5 billion as company revenue swelled 77%, the company said Tuesday. Pfizer posted adjusted earnings of $1.62 per share in the first quarter, on $25.66 billion in revenue. Analysts expected per-share earnings of $1.49 on about $24.1 billion in sales, according to FactSet. Pfizer Inc., based in New York, also revised its 2022 earnings forecast to reflect an accounting policy change. It now expects adjusted earnings of $6.25 to $6.45 per share. That's down from its previous forecast for $6.35 to $6.55 per share. Analysts forecast earnings of $7.14 per share. Shares ticked slightly higher before the opening bell Thursday. [url="https://www.local10.com/business/2022/05/03/pfizer-tops-q1-expectations-revises-2022-forecast/"]Continue reading...[/url] [/QUOTE]
Loading…
Insert quotes…
Verification
Post reply
Information
World News
Pfizer tops Q1 expectations, revises 2022 forecast
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top